EXAGEN INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Exagen Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q3 2024.
Exagen Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $217K, a 75.6% decline year-over-year.
Exagen Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.09M, a 39.1% decline year-over-year.
Exagen Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.62M, a 23.1% decline from 2022.
Exagen Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.7M, a 0.51% decline from 2021.
Exagen Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.73M, a 75.5% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$2.09M	$217K	-$673K	-75.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$2.77M	$560K	-$418K	-42.7%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$3.18M	$553K	-$433K	-43.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$3.62M	$763K	+$181K	+31.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	$3.44M	$890K	-$416K	-31.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	$3.85M	$978K	-$462K	-32.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-05
Q1 2023	$4.31M	$986K	-$390K	-28.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	$4.7M	$582K	-$595K	-50.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	$5.3M	$1.31M	-$48K	-3.55%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$5.35M	$1.44M	+$155K	+12.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	$5.19M	$1.38M	+$464K	+50.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$4.73M	$1.18M	+$360K	+44.1%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$4.37M	$1.35M	+$555K	+69.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-21
Q2 2021	$3.81M	$1.29M	+$638K	+98.6%	Apr 1, 2021	Jun 30, 2021	10-Q/A	2022-11-21
Q1 2021	$3.18M	$912K	+$481K	+112%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$2.69M	$817K	+$330K	+67.8%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-22
Q3 2020	$2.36M	$799K	+$737K	+1189%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$1.63M	$647K	+$636K	+5782%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$991K	$431K	+$419K	+3492%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	$572K	$487K			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-16
Q3 2019		$62K	+$52K	+520%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019		$11K			Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-28
Q1 2019		$12K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q3 2018		$10K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.